Vascular Biogenics Ltd. logo

Vascular Biogenics Ltd.

NASDAQ:VBLT

Overview | Financials
Company Name Vascular Biogenics Ltd.
Symbol VBLT
Currency USD
Price 0.156
Market Cap 12,111,917
Dividend Yield 0%
52-week-range 0.101 - 0.32
Industry Biotechnology
Sector Healthcare
CEO Prof. Dror Harats M.D.
Website https://www.vblrx.com

An error occurred while fetching data.

About Vascular Biogenics Ltd.

Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables

Related Stocks

Portage Biotech Inc. logo

Portage Biotech Inc.

PRTG

6.71 USD

Omega Therapeutics, Inc. logo

Omega Therapeutics, Inc.

OMGA

1.04 USD

Societal CDMO, Inc. logo

Societal CDMO, Inc.

SCTL

1.1 USD

INmune Bio, Inc. logo

INmune Bio, Inc.

INMB

5 USD

ChromaDex Corporation logo

ChromaDex Corporation

CDXC

3.44 USD

Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc.

ATOS

1.45 USD

Checkpoint Therapeutics, Inc. logo

Checkpoint Therapeutics, Inc.

CKPT

2.97 USD

Financials

Numbers are in millions USD

Numbers are in millions USD